Physician profile
Marvin Maxwell
NPI 1720001209
$12,644.44
in general payments reported to CMS, 2019-2025
59 companies · $2,096 in 2025
The $2,096 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,558 · 2020: $1,214 · 2021: $2,556 · 2022: $2,013 · 2023: $1,414 · 2024: $1,794 · 2025: $2,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,303.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,503.17 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,421.01 | 2019-2025 | |
| Novo Nordisk INC | $887.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $638.71 | 2021-2025 | |
| Amgen INC. | $530.88 | 2019-2025 | Repatha, Evenity, Prolia |
| Pfizer INC. | $448.64 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $413.69 | 2019-2025 | |
| Corcept Therapeutics | $320.78 | 2023-2025 | Korlym |
| Esperion Therapeutics, INC. | $306.40 | 2020-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.32 | 2020-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $295.32 | 2019-2024 | Belsomra, Steglatro, Verquvo |
| Lilly USA, LLC | $274.17 | 2019-2023 | Mounjaro, Trulicity |
| Sanofi-Aventis U.S. LLC | $270.87 | 2019-2024 | |
| Allergan, INC. | $261.16 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $240.66 | 2019-2023 | Xarelto |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $231.51 | 2022-2025 | Rexulti |
| Mylan Specialty L.P. | $226.60 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $200.90 | 2022 | |
| Amarin Pharma, INC. | $196.69 | 2019-2021 | |
| Antares Pharma, INC. | $186.07 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Exact Sciences Corporation | $182.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $166.05 | 2025 | Auvelity |
| Glaxosmithkline, LLC. | $162.94 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Eisai INC. | $141.14 | 2020-2025 | |
| Radius Health, INC. | $137.70 | 2019-2023 | Tymlos |
| Phathom Pharmaceuticals, INC. | $119.32 | 2024 | Voquezna |
| Abbott Laboratories | $115.59 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $107.38 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Dexcom, INC. | $98.45 | 2024-2025 | Dexcom G6 Transmitter |
| Vertos Medical, INC. | $97.77 | 2022 | |
| Sunovion Pharmaceuticals INC. | $89.06 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.31 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $76.36 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.88 | 2019 | |
| Idorsia Pharmaceuticals US INC | $70.05 | 2023-2024 | Quviviq |
| Horizon Therapeutics Plc | $68.61 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $67.53 | 2022-2023 | Ztlido |
| Halozyme INC | $66.37 | 2023 | |
| Bausch Health US, LLC | $63.92 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $63.10 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.26 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $47.55 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Vanda Pharmaceuticals INC. | $45.73 | 2023 | Hetlioz, Fanapt |
| Teva Pharmaceuticals USA, INC. | $38.29 | 2022 | |
| Biodelivery Sciences International, INC. | $26.26 | 2019-2020 | |
| Averitas Pharma INC. | $25.17 | 2025 | Qutenza |
| Insulet Corporation | $21.88 | 2025 | Omnipod |
| Genentech USA, INC. | $21.10 | 2019 | |
| Upsher-Smith Laboratories LLC | $20.34 | 2022 | |
| Ironwood Pharmaceuticals, INC | $19.69 | 2019 | |
| Tonix Medicines, INC. | $17.09 | 2025 | Tonmya |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.24 | 2025 | Caplyta |
| Philips North America LLC | $15.21 | 2024 | (Ck7) Extended Holter |
| Electromed, INC. | $13.93 | 2025 | Smartvest |
| Cashflow Solutions, LLC | $13.78 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Jazz Pharmaceuticals INC. | $12.19 | 2021 | |
| Vivus LLC | $11.68 | 2021 | |
| Ethicon US, LLC | $11.09 | 2019 | |
| Kvk-Tech, INC. | $1.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.